GB9825303D0 - Vector - Google Patents

Vector

Info

Publication number
GB9825303D0
GB9825303D0 GBGB9825303.2A GB9825303A GB9825303D0 GB 9825303 D0 GB9825303 D0 GB 9825303D0 GB 9825303 A GB9825303 A GB 9825303A GB 9825303 D0 GB9825303 D0 GB 9825303D0
Authority
GB
United Kingdom
Prior art keywords
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9825303.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Biomedica UK Ltd
Original Assignee
Oxford Biomedica UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica UK Ltd filed Critical Oxford Biomedica UK Ltd
Priority to GBGB9825303.2A priority Critical patent/GB9825303D0/en
Publication of GB9825303D0 publication Critical patent/GB9825303D0/en
Priority to PCT/GB1999/003859 priority patent/WO2000029428A2/en
Priority to JP2000582415A priority patent/JP4907767B2/en
Priority to GB0127675A priority patent/GB2370573A/en
Priority to GB0224538A priority patent/GB2378704B/en
Priority to GB0014986A priority patent/GB2347932B/en
Priority to CA002351622A priority patent/CA2351622A1/en
Priority to GB0127673A priority patent/GB2370572B/en
Priority to CNA2006101689765A priority patent/CN101134101A/en
Priority to CN 200610168977 priority patent/CN101134102B/en
Priority to AT99972219T priority patent/ATE293690T1/en
Priority to GB0127669A priority patent/GB2370571B/en
Priority to EP01201448A priority patent/EP1160323A1/en
Priority to EP01201447.8A priority patent/EP1152060B1/en
Priority to KR1020017006155A priority patent/KR20010084935A/en
Priority to CNB998156329A priority patent/CN1298851C/en
Priority to EP09000205A priority patent/EP2042598A1/en
Priority to DE69924826T priority patent/DE69924826T8/en
Priority to AU13949/00A priority patent/AU766954B2/en
Priority to EP99972219A priority patent/EP1036091B2/en
Priority to US09/533,798 priority patent/US7148035B1/en
Priority to US10/774,176 priority patent/US20040265275A1/en
Priority to US11/286,056 priority patent/US7601698B2/en
Priority to US11/456,530 priority patent/US20090191230A1/en
Priority to US11/532,816 priority patent/US7666669B2/en
Priority to US11/686,793 priority patent/US7615612B2/en
Priority to US12/637,350 priority patent/US20100233126A1/en
Ceased legal-status Critical Current

Links

GBGB9825303.2A 1998-11-18 1998-11-18 Vector Ceased GB9825303D0 (en)

Priority Applications (27)

Application Number Priority Date Filing Date Title
GBGB9825303.2A GB9825303D0 (en) 1998-11-18 1998-11-18 Vector
EP99972219A EP1036091B2 (en) 1998-11-18 1999-11-18 5t4 tumour-associated antigen for use in tumour immunotherapy
EP01201448A EP1160323A1 (en) 1998-11-18 1999-11-18 5T4 tumour-associated antigen for use in tumour immunotherapy
KR1020017006155A KR20010084935A (en) 1998-11-18 1999-11-18 Polypeptide
GB0127675A GB2370573A (en) 1998-11-18 1999-11-18 Poxviral vectors
GB0224538A GB2378704B (en) 1998-11-18 1999-11-18 Uses of 5t4 antigen
GB0014986A GB2347932B (en) 1998-11-18 1999-11-18 Vectors for the delivery of 5T4 antigen
CA002351622A CA2351622A1 (en) 1998-11-18 1999-11-18 Polypeptide
GB0127673A GB2370572B (en) 1998-11-18 1999-11-18 Use of a professional antigen presenting cell
CNA2006101689765A CN101134101A (en) 1998-11-18 1999-11-18 5T4 tumour-associated antigen
CN 200610168977 CN101134102B (en) 1998-11-18 1999-11-18 5T4 antigen-expressed vector
AT99972219T ATE293690T1 (en) 1998-11-18 1999-11-18 USE OF CANCER-ASSOCIATED ANTIGEN 5T4 FOR IMMUNOTHERAPY
GB0127669A GB2370571B (en) 1998-11-18 1999-11-18 A modified 5t4 antigen
PCT/GB1999/003859 WO2000029428A2 (en) 1998-11-18 1999-11-18 5t4 tumour-associated antigen for use in tumour immunotherapy
EP01201447.8A EP1152060B1 (en) 1998-11-18 1999-11-18 5T4 tumour-associated antigen for use in tumour immunotherapy
JP2000582415A JP4907767B2 (en) 1998-11-18 1999-11-18 Polypeptide
CNB998156329A CN1298851C (en) 1998-11-18 1999-11-18 Polypeptide
EP09000205A EP2042598A1 (en) 1998-11-18 1999-11-18 5T4 tumour-associated antigen for use in tumour immunotherapy
DE69924826T DE69924826T8 (en) 1998-11-18 1999-11-18 USE OF CANCER ASSOCIATED ANTIGEN 5T4 TO IMMUNE THERAPY
AU13949/00A AU766954B2 (en) 1998-11-18 1999-11-18 Polypeptide
US09/533,798 US7148035B1 (en) 1998-11-18 2000-03-24 Polypeptide
US10/774,176 US20040265275A1 (en) 1998-11-18 2004-02-06 Polypeptide
US11/286,056 US7601698B2 (en) 1998-11-18 2005-11-22 Polypeptide
US11/456,530 US20090191230A1 (en) 1998-11-18 2006-07-10 Cascade
US11/532,816 US7666669B2 (en) 1998-11-18 2006-09-18 Polypeptide
US11/686,793 US7615612B2 (en) 1998-11-18 2007-03-15 Polypeptide
US12/637,350 US20100233126A1 (en) 1998-11-18 2009-12-14 Polypeptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9825303.2A GB9825303D0 (en) 1998-11-18 1998-11-18 Vector

Publications (1)

Publication Number Publication Date
GB9825303D0 true GB9825303D0 (en) 1999-01-13

Family

ID=10842667

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9825303.2A Ceased GB9825303D0 (en) 1998-11-18 1998-11-18 Vector

Country Status (2)

Country Link
CN (2) CN101134102B (en)
GB (1) GB9825303D0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110698559B (en) * 2015-12-24 2021-11-26 凯惠科技发展(上海)有限公司 TPBG antibody, preparation method thereof, conjugate thereof and application thereof
KR20230166145A (en) * 2017-03-15 2023-12-06 옥스포드 바이오메디카(유케이) 리미티드 Method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0403559A1 (en) * 1988-03-04 1990-12-27 Cancer Research Campaign Technology Limited Improvements relating to antigens

Also Published As

Publication number Publication date
CN101134102B (en) 2013-09-18
CN101134101A (en) 2008-03-05
CN101134102A (en) 2008-03-05

Similar Documents

Publication Publication Date Title
DE59912932D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE59912303D1 (en) Arylphenylsubstituierte cyclische ketoenole
DE69904335D1 (en) Aminomethylcarbonsäurederivate
DE69835235D1 (en) Thermoplastische silikonelastomere
DE59903023D1 (en) Perorale wirkstoff-suspension
DE59914151D1 (en) Arylalkanoylpyridazine
DE69908871D1 (en) Thermisch härtbare glasplatte
GB0108870D0 (en) Vector
DE69904442D1 (en) Cyclohexandiol-derivate
AU136536S (en) Case
DE59904407D1 (en) Chromanderivate
IL140461A0 (en) Propionibacterium vector
DE69821502D1 (en) Boroskop
TW395202U (en) Carrying case
DE59900495D1 (en) Multimetalloxidmassen
GB9906615D0 (en) Vector
DE59900471D1 (en) Inchbremseinrichtung
DE69905174D1 (en) Hydroperoxidzersetzungsverfahren
DE69902586D1 (en) Expandierte ethylencopolymere
GB9825303D0 (en) Vector
DE59905941D1 (en) Methoximinophenylessigsäureamide
GB9811171D0 (en) Viral vector
GB9909446D0 (en) Vector
DE59911094D1 (en) Tryptase-inhibitoren
GB9825544D0 (en) Vector

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)